Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Diabetes 54, 2988-2994
CRC Press, Boca Raton, FL, 1996 263-276
However, the existing evidence is limited by small cohort sizes, heterogeneous patient populations, and confounding effects of concurrent therapies, limiting its generalizability
Furthermore, the cardiovascular benefits emerged early in treatment, preceding significant weight loss, suggesting that the cardiovascular effects may be mediated, at least partially, by other salutary processes in atherosclerotic protection
doi: 10.3389/fped.2017.00121 13 Centers for Disease Control and Prevention
US$ 20.59
US$ 25.17
US$ 20.35
US$ 22.34
US$ 27.05
